SlideShare a Scribd company logo
1 of 21
3-D PRINTING AND ITS
APPLICATION IN PHARMACY
SUBMITTED BY: PRACHI PANDEY, RAHUL PAL SUBMITTED TO: MR. ARSH CHANANA
M. PHARM (PHARMACEUTICS), IInd SEM.
DEPARTMENT OF PHARMACEUTICS, NIMS INSTITUTE OF PHARMACY, NIMS UNIVERSITY JAIPUR,
RAJASTHAN INDIA
3- D PRINTING (3DP)
 Drug delivery is the main technology which is used to efficiently transport a pharmacologically active
compound in the body to achieve therapeutic efficiency in a safe manner.
 Three D (3D) technology has high potential in individualized dosage form.
 3D printing is a versatile tool for precise manufacturing of various devices. This technology is now been
used for developing novel dosage form and engineering of tissues and organs (1,2).
 It also been utilized for developing of models for a particular disease.
 ISO(International standard organization) has defined 3D printing as fabrication of objects through the
deposition of material using a print head, nozzle or another printer technology
HISTORY
 The 3D-Printing posed as a possible platform for personalized medicine in the 1990s(5).
 Inkjet printing was the 1st 3D printing technique.
 This technique was invented in the early 90’s at the Massachuset Institute Technology and further
patented by Sachs et al (6)
 The first 3D printed drug was approved by the Food and Drug Administration (FDA) in the year
2016.
 Approval of first 3D printed pill was in August in the year 2015 by FDA.
ADVANTAGES OF 3-D PRINTING
 3D printing has high loading ability in comparison to conventional dosage form.
 3D printing has an important advantage of minimal space and they are affordable for pharmaceutical
industries
 3D printing is used to reduce the cost of production because of lesser wastage of material
 It is difficult to formulate active ingredients which has poor solubility, poor water solubility
 Tailoring of drug dose. It allows drugs to be printed in various layers thereby allow making of drug
combination to treat multiple to single pills
 Unique dosage form
 It enables researcher to understand how a drug is broken release when it is administered to patient.
Figure. 01 3-D Printing (3DP)Techniques
TYPES OF 3-D PRINTERS
 Inkjet 3-d printer
 Laser based writing system
 Stereolithographic 3D printing
 Nozzle based deposition system
 Selective laser sintering 3D printing
 Powder based 3D printing
INKJET 3-D PRINTERS
 Inkjet printing is a type of 3D printing technique used in
personalized medicine.
 Its concept originated from the operated inkjet printing.
 It was modified for pharmaceutical application by the
replacement of ink with pharmaceutical solutions which
comprised drugs and normal paper with edible sheets as
substrates.
 The liquid which is used in inkjet printing is directed
through an orifice of 50-80 µm.
 The liquid is caused to flow and break into drops at a
specified speed and size at regular intervals using a
piezoelectric crystal.
LASER BASED WRITING SYSTEM
 It is a type of 3D printing technique which runs
on the principle of photopolymerization.
 In this, free radicals are released after
interaction between Photo initiator and UV
light.
STEREOLITHOGRAPHIC 3D PRINTING
 This technique shows the involvement of
photosensitive material to produce a 3D project.
 In this technique focused Ultraviolet (UV) laser
is scanned over the top of a photopolymerizable
liquid in a layer by layer fashion.
 SLA printers are composed of an ultraviolet
light beam, in the form of a laser, which is used
to transfer the energy into a liquid photo
polymerizable resin.
NOZZLE BASED DEPOSITION SYSTEM
 It is a type of technique which is used for mixing the
solid components with the binder prior to 3D printing
and directly deposit the mixture through a nozzle to
create a 3D object. This method can be divided into
two subtypes, named fused deposition modeling
(FDM) and pressure-assisted microsyringes
 FDM is one of the most commonly used 3DP
techniques and has been well-studied in many fields,
including pharmaceuticals, foods, and
bioengineering.
 PAM(pressure assisted microsyringe) is another
nozzle-based deposition system. In PAM, viscous and
semi-liquid materials are extruded from a micro
syringe. PAM technology allows producing
microstructure of 5–10 µm or less.
Levetiracetam and Pseudoephedrine HCl are
examples of nozzle based systems.
SELECTIVE LASER SINTERING 3D PRINTING
 This is a type of 3D printing technique. It
involves powder bed being spread as thin layer
laser radiations assessed to liquefy and fuse the
powder layers. A lesser used method due to
chemical degradation. The laser beam sinters
the powder and binds it in layer by layer
fashion.
POWDER BASED 3D PRINTING
 Powder based 3D printing uses powder jetting
or powder bed to spread thin layers of powder
and simultaneously apply liquid binder drops
with the help of inkjet printers.
 The ink (binders and APIs or Binder solutions)
is sprinkled over a powder bed in two
dimensional fashion to make the final product in
a layer by layer fashion(12).
CHALLENGES FACED DURING 3D PRINTING
There are some challenges which are faced during 3D printing technique
 Raw Material Selection:
Printability, physiochemical characteristics, thermal conductivity are important factors. Print fluid
characterization and viscoelastic property has to be carefully analysed with safety of raw material for
human use.
 Nozzle Selection:
Nozzle mechanism is used for the dosage form during 3D printing. Some problems faced during this
level are dogging of nozzles in printer head, scraping, migration of binder, bleeding and improper
powder feeding.
 Surface Imperfection In finished Product:
Arrangement of plastic beads or large sized powder on top of each other requires drying time for the
dosage form with powder based techniques and hence there is more possibility of surface imperfection
APPLICATIONS OF 3-D PRINTING
APPLICATION OF 3DP TECHNOLOGY TO
PHARMACEUTICAL DOSAGE FORMS
3DP technologies such as IJ(inkjet printing), FDM(fusion deposition modelling), and SLS(selective laser
sintering) are currently available for manufacturing adequate pharmaceutical dosage forms
 Tablets
Tablets and capsules are examples of solid oral dosage forms. Tablets have been extensively
examined for the feasibility of 3DP technologies in pharmaceutical manufacturing.
Tablets produced by 3DP methods can be categorized into two groups: Single API tablets and Multiple
API tablets.
 Single API tablets
3DP technology was applied to fabricate simple immediate release (IR) tablets comprising a single.
For example, a thermoplastic polyurethane-based dosage form loaded with 60% drug was successfully
developed via the FDM(fusion deposition modeling)
APPLICATION OF 3DP TECHNOLOGY TO
PHARMACEUTICAL DOSAGE FORMS
 Cellulose (EC/HPC/HPMC)/Eudragit L100,
Ethylene vinyl acetate, hydroxypropyl cellulose,
ethyl cellulose.
 Multiple API tablets
To combine complex medication regimes into
one, multiple APIs can be loaded in a single
tablet, called a poly pill
The tablet is composed of three components,
such as a surface-eroding polymer with the
drug, surface-eroding polymer without the drug,
and an impermeable polymer that forms a
protective coating
Figure 2- Polypills containing multiple
active ingredients (APIs). a Polypill with
three APIs, b polypill with five APIs
APPLICATION OF 3DP TECHNOLOGY TO
PHARMACEUTICAL DOSAGE FORMS
 Microneedles:
 Microneedles are a class of transdermal drug delivery systems, which has arrays of micron-sized
needles on the surface of a matrix to enhance the skin penetration of biologically active molecules.
 Microneedles may be more effective to deliver through the skin than traditional patches, due to its
microstructure.
 For eg: polymeric microneedles of complex geometries, by coupling 3DP with hydrogels
casting/shrinking techniques
NEED OF 3D PRINTING IN PHARMACEUTICALS
3D printing is used for personalized medicine and improvements in clinical trials, benefitting patients and
manufacturers in pharmaceutical industry
 Controlled Release:
In controlled release systems, 3D Printing is used because of their tendency to change shape during
digestion or operate for extended times, is growing as patients’ desire for convenience expands.
Paediatric care is a key application area for extended-release pharmaceuticals.
Extended release is an example of controlled release systems
 Enhanced productivity:
3D printing technology is much faster than traditional method of drug manufacturing their tendency to
change shape during digestion or operate for extended times
NEED OF 3D PRINTING IN PHARMACEUTICALS
 Short-Run Medicines:
The short-run medicines which are used for 3D manufacturing themselves to patient-specific drugs
3D printing cans also use for clinical trial process through speed and flexibility and its ability to
produce small batches of drugs with different compositions. With 3D printing, companies can create
multiple versions of a drug for variant populations and produce them in short-run batches.
CONCLUSION
 3D printing technology is used for pharmaceutical manufacturing style and formulation techniques.
 It is an important tool for pharmaceutical sector and health care sector. It is used as a personalized
medicine which focused on the patients.It has high potential in individual dosage form.
 3D printing is a possible platform for personalized medicine. Such techniques are also involved in 3D
printing in pharmaceuticals for e.g. inkjet printing, powder based technology, etc.
 Some need for 3D printing in pharmaceuticals. It can increase the cost. It is also used for enhancing
productivity.
 It is used for controlled release of drug, for enhancing productivity, and also for short run medicines
REFERENCE
 Norman J, Madurawe R, Moore C, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical
manufacturing: 3D-printed drug products. Advanced Drug Delivery Reviews.2017; 108:39-50.
 Dingo JH. 3D Printing of Pharmaceutical Drug Delivery Systems. Archives of Organic and Inorganic
Chemical Sciences.2018; 1(2).AOICS.MS.ID.000109.
 Food and Drug Administration, 2017. Guidance for Industry: Technical Considerations for Additive
Manufactured Medical Devices. Center for Devices and Radiological Health Center for Biologics
Evaluation and Research, U.S. Department of Health and Human Services.
 https://www.fda.gov/http://cbm.msoe.edu/markMyweb/printResources/documen
ts/historyOf3DPrinting.pdf 7. Wang, J, Goyanes A, Gaisford S, Basit AW. Stereolithographic (SLA)

More Related Content

What's hot

What's hot (20)

Telepharmacy
TelepharmacyTelepharmacy
Telepharmacy
 
Drug excipient interaction different method
Drug excipient interaction different methodDrug excipient interaction different method
Drug excipient interaction different method
 
3 d printing of pharmaceuticals
3 d printing  of  pharmaceuticals 3 d printing  of  pharmaceuticals
3 d printing of pharmaceuticals
 
DIffusion, Dissolution and Pharmacokinetic Parameters.pptx
DIffusion, Dissolution and Pharmacokinetic Parameters.pptxDIffusion, Dissolution and Pharmacokinetic Parameters.pptx
DIffusion, Dissolution and Pharmacokinetic Parameters.pptx
 
Compaction profiles
Compaction profilesCompaction profiles
Compaction profiles
 
Preformation supriya
Preformation supriyaPreformation supriya
Preformation supriya
 
Compression and Compaction
Compression and CompactionCompression and Compaction
Compression and Compaction
 
Objectives and policies of cGMP & Inventory management and control
Objectives and policies of cGMP & Inventory management and controlObjectives and policies of cGMP & Inventory management and control
Objectives and policies of cGMP & Inventory management and control
 
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...
 
API, BIOLOGICS,NOVEL,THERAPIES........pptx
API, BIOLOGICS,NOVEL,THERAPIES........pptxAPI, BIOLOGICS,NOVEL,THERAPIES........pptx
API, BIOLOGICS,NOVEL,THERAPIES........pptx
 
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESREGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
 
Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRO
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compaction
 
Compaction profile
Compaction profileCompaction profile
Compaction profile
 
Us registration for foreign drugs
Us registration for foreign drugsUs registration for foreign drugs
Us registration for foreign drugs
 
Preformulation concept
Preformulation conceptPreformulation concept
Preformulation concept
 
Mechanical and pH activated DDS.pptx
Mechanical and pH activated DDS.pptxMechanical and pH activated DDS.pptx
Mechanical and pH activated DDS.pptx
 
Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRO
 
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGARegulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGA
 
Impd
ImpdImpd
Impd
 

Similar to 3-D Printing and Application in Pharmaceutical.pptx

Similar to 3-D Printing and Application in Pharmaceutical.pptx (20)

3-D and application.pptx
3-D and application.pptx3-D and application.pptx
3-D and application.pptx
 
3D PRINTING AND ITS RECENT ADVANCEMENTS
3D PRINTING AND ITS RECENT ADVANCEMENTS3D PRINTING AND ITS RECENT ADVANCEMENTS
3D PRINTING AND ITS RECENT ADVANCEMENTS
 
3 D printing technology in pharmaceutical drug delivery system
3 D printing technology in pharmaceutical drug delivery system3 D printing technology in pharmaceutical drug delivery system
3 D printing technology in pharmaceutical drug delivery system
 
A review on 3D printing in Pharmaceuticals
A review on 3D printing in PharmaceuticalsA review on 3D printing in Pharmaceuticals
A review on 3D printing in Pharmaceuticals
 
3d printing in pharmaceuticals
3d printing in pharmaceuticals3d printing in pharmaceuticals
3d printing in pharmaceuticals
 
3D Printing of Drugs
3D Printing of Drugs3D Printing of Drugs
3D Printing of Drugs
 
3D PRINTING OF PHARMACEUTICALS-1.pptx novel drug delivery
3D PRINTING OF PHARMACEUTICALS-1.pptx novel drug delivery3D PRINTING OF PHARMACEUTICALS-1.pptx novel drug delivery
3D PRINTING OF PHARMACEUTICALS-1.pptx novel drug delivery
 
Nano-Technology Printing in Pharmaceuticals (Hi-Res)
Nano-Technology Printing in Pharmaceuticals (Hi-Res)Nano-Technology Printing in Pharmaceuticals (Hi-Res)
Nano-Technology Printing in Pharmaceuticals (Hi-Res)
 
3D Printing -A new chapter in pharmaceutical manufacturing
3D Printing -A new chapter in pharmaceutical manufacturing3D Printing -A new chapter in pharmaceutical manufacturing
3D Printing -A new chapter in pharmaceutical manufacturing
 
3D Printing in Pharmaceuticals science.pptx
3D Printing in Pharmaceuticals science.pptx3D Printing in Pharmaceuticals science.pptx
3D Printing in Pharmaceuticals science.pptx
 
3 D Printing of pharmaceuticals
3 D Printing of pharmaceuticals3 D Printing of pharmaceuticals
3 D Printing of pharmaceuticals
 
3D PRINTING ROLE IN PHARMACY FIELDS.pptx
3D PRINTING ROLE IN PHARMACY FIELDS.pptx3D PRINTING ROLE IN PHARMACY FIELDS.pptx
3D PRINTING ROLE IN PHARMACY FIELDS.pptx
 
NanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdfNanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdf
 
3 d printing technology an innovative hope for health care 13.02.2020
3 d printing technology an innovative hope for health care 13.02.20203 d printing technology an innovative hope for health care 13.02.2020
3 d printing technology an innovative hope for health care 13.02.2020
 
3 d printing technology an innovative hope for health care 13.02.2020
3 d printing technology an innovative hope for health care 13.02.20203 d printing technology an innovative hope for health care 13.02.2020
3 d printing technology an innovative hope for health care 13.02.2020
 
Innovation In Pharmaceutical Tablet Manufacturing
Innovation In Pharmaceutical Tablet ManufacturingInnovation In Pharmaceutical Tablet Manufacturing
Innovation In Pharmaceutical Tablet Manufacturing
 
3 d printing of pharmaceuticals
3 d printing of pharmaceuticals3 d printing of pharmaceuticals
3 d printing of pharmaceuticals
 
3 d printing in pharmaceutcials
3 d printing in pharmaceutcials3 d printing in pharmaceutcials
3 d printing in pharmaceutcials
 
3D printed tablets.pptx
3D printed tablets.pptx3D printed tablets.pptx
3D printed tablets.pptx
 
3d printing in Pharmaceutical Industry.pptx
3d printing in Pharmaceutical Industry.pptx3d printing in Pharmaceutical Industry.pptx
3d printing in Pharmaceutical Industry.pptx
 

More from Prachi Pandey

More from Prachi Pandey (20)

SURFACTANT SURFACE ACTIVE AGENT.pptx
SURFACTANT SURFACE ACTIVE AGENT.pptxSURFACTANT SURFACE ACTIVE AGENT.pptx
SURFACTANT SURFACE ACTIVE AGENT.pptx
 
Nucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptxNucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptx
 
Code of Pharmaceuticalethics.pdf
Code of Pharmaceuticalethics.pdfCode of Pharmaceuticalethics.pdf
Code of Pharmaceuticalethics.pdf
 
Emollient and Rheological Additive.pptx
Emollient and Rheological Additive.pptxEmollient and Rheological Additive.pptx
Emollient and Rheological Additive.pptx
 
CDSCO Regulatory Authority.pdf
CDSCO Regulatory Authority.pdfCDSCO Regulatory Authority.pdf
CDSCO Regulatory Authority.pdf
 
IUD- Drug Delivery System .pdf
IUD- Drug Delivery System .pdfIUD- Drug Delivery System .pdf
IUD- Drug Delivery System .pdf
 
In-Vitro-In Vivo (IVIVC).pdf
In-Vitro-In Vivo (IVIVC).pdfIn-Vitro-In Vivo (IVIVC).pdf
In-Vitro-In Vivo (IVIVC).pdf
 
Microspheres Preparation and Evaluations.pdf
Microspheres Preparation and Evaluations.pdfMicrospheres Preparation and Evaluations.pdf
Microspheres Preparation and Evaluations.pdf
 
Imports of Drugs .pdf
Imports of Drugs .pdfImports of Drugs .pdf
Imports of Drugs .pdf
 
Pharmaceutical Jurisprudence.pdf
Pharmaceutical Jurisprudence.pdfPharmaceutical Jurisprudence.pdf
Pharmaceutical Jurisprudence.pdf
 
Morphine and Related Drugs including their Derivatives.pdf
Morphine and Related Drugs including their Derivatives.pdfMorphine and Related Drugs including their Derivatives.pdf
Morphine and Related Drugs including their Derivatives.pdf
 
Behavioural Science.pdf
Behavioural Science.pdfBehavioural Science.pdf
Behavioural Science.pdf
 
BEHAVIOUR SCIENCE INTERDISCIPINARY PROJECT.pdf
BEHAVIOUR SCIENCE INTERDISCIPINARY PROJECT.pdfBEHAVIOUR SCIENCE INTERDISCIPINARY PROJECT.pdf
BEHAVIOUR SCIENCE INTERDISCIPINARY PROJECT.pdf
 
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptxREGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
 
Pro-Drug and Active Drug In Medicinal Chemistry.ppt
Pro-Drug and Active Drug In Medicinal Chemistry.pptPro-Drug and Active Drug In Medicinal Chemistry.ppt
Pro-Drug and Active Drug In Medicinal Chemistry.ppt
 
International Conference on Fostering High Quality Clinical Research for A He...
International Conference on Fostering High Quality Clinical Research for A He...International Conference on Fostering High Quality Clinical Research for A He...
International Conference on Fostering High Quality Clinical Research for A He...
 
In vitro dissolution, Alternative Methods.pptx
In vitro dissolution, Alternative Methods.pptxIn vitro dissolution, Alternative Methods.pptx
In vitro dissolution, Alternative Methods.pptx
 
In vitro dissolution apparatus USP.pptx
In vitro dissolution apparatus USP.pptxIn vitro dissolution apparatus USP.pptx
In vitro dissolution apparatus USP.pptx
 
Calculation of various pharmacokinetics parameters after IV Bolusinjection.pdf
Calculation of various pharmacokinetics parameters after IV Bolusinjection.pdfCalculation of various pharmacokinetics parameters after IV Bolusinjection.pdf
Calculation of various pharmacokinetics parameters after IV Bolusinjection.pdf
 
Polymers Used as Biopolymer in Product Formulations.
Polymers Used as Biopolymer in Product Formulations.Polymers Used as Biopolymer in Product Formulations.
Polymers Used as Biopolymer in Product Formulations.
 

Recently uploaded

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 

Recently uploaded (20)

How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Basic Intentional Injuries Health Education
Basic Intentional Injuries Health EducationBasic Intentional Injuries Health Education
Basic Intentional Injuries Health Education
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 

3-D Printing and Application in Pharmaceutical.pptx

  • 1. 3-D PRINTING AND ITS APPLICATION IN PHARMACY SUBMITTED BY: PRACHI PANDEY, RAHUL PAL SUBMITTED TO: MR. ARSH CHANANA M. PHARM (PHARMACEUTICS), IInd SEM. DEPARTMENT OF PHARMACEUTICS, NIMS INSTITUTE OF PHARMACY, NIMS UNIVERSITY JAIPUR, RAJASTHAN INDIA
  • 2. 3- D PRINTING (3DP)  Drug delivery is the main technology which is used to efficiently transport a pharmacologically active compound in the body to achieve therapeutic efficiency in a safe manner.  Three D (3D) technology has high potential in individualized dosage form.  3D printing is a versatile tool for precise manufacturing of various devices. This technology is now been used for developing novel dosage form and engineering of tissues and organs (1,2).  It also been utilized for developing of models for a particular disease.  ISO(International standard organization) has defined 3D printing as fabrication of objects through the deposition of material using a print head, nozzle or another printer technology
  • 3. HISTORY  The 3D-Printing posed as a possible platform for personalized medicine in the 1990s(5).  Inkjet printing was the 1st 3D printing technique.  This technique was invented in the early 90’s at the Massachuset Institute Technology and further patented by Sachs et al (6)  The first 3D printed drug was approved by the Food and Drug Administration (FDA) in the year 2016.  Approval of first 3D printed pill was in August in the year 2015 by FDA.
  • 4. ADVANTAGES OF 3-D PRINTING  3D printing has high loading ability in comparison to conventional dosage form.  3D printing has an important advantage of minimal space and they are affordable for pharmaceutical industries  3D printing is used to reduce the cost of production because of lesser wastage of material  It is difficult to formulate active ingredients which has poor solubility, poor water solubility  Tailoring of drug dose. It allows drugs to be printed in various layers thereby allow making of drug combination to treat multiple to single pills  Unique dosage form  It enables researcher to understand how a drug is broken release when it is administered to patient.
  • 5. Figure. 01 3-D Printing (3DP)Techniques
  • 6. TYPES OF 3-D PRINTERS  Inkjet 3-d printer  Laser based writing system  Stereolithographic 3D printing  Nozzle based deposition system  Selective laser sintering 3D printing  Powder based 3D printing
  • 7. INKJET 3-D PRINTERS  Inkjet printing is a type of 3D printing technique used in personalized medicine.  Its concept originated from the operated inkjet printing.  It was modified for pharmaceutical application by the replacement of ink with pharmaceutical solutions which comprised drugs and normal paper with edible sheets as substrates.  The liquid which is used in inkjet printing is directed through an orifice of 50-80 µm.  The liquid is caused to flow and break into drops at a specified speed and size at regular intervals using a piezoelectric crystal.
  • 8. LASER BASED WRITING SYSTEM  It is a type of 3D printing technique which runs on the principle of photopolymerization.  In this, free radicals are released after interaction between Photo initiator and UV light.
  • 9. STEREOLITHOGRAPHIC 3D PRINTING  This technique shows the involvement of photosensitive material to produce a 3D project.  In this technique focused Ultraviolet (UV) laser is scanned over the top of a photopolymerizable liquid in a layer by layer fashion.  SLA printers are composed of an ultraviolet light beam, in the form of a laser, which is used to transfer the energy into a liquid photo polymerizable resin.
  • 10. NOZZLE BASED DEPOSITION SYSTEM  It is a type of technique which is used for mixing the solid components with the binder prior to 3D printing and directly deposit the mixture through a nozzle to create a 3D object. This method can be divided into two subtypes, named fused deposition modeling (FDM) and pressure-assisted microsyringes  FDM is one of the most commonly used 3DP techniques and has been well-studied in many fields, including pharmaceuticals, foods, and bioengineering.  PAM(pressure assisted microsyringe) is another nozzle-based deposition system. In PAM, viscous and semi-liquid materials are extruded from a micro syringe. PAM technology allows producing microstructure of 5–10 µm or less. Levetiracetam and Pseudoephedrine HCl are examples of nozzle based systems.
  • 11. SELECTIVE LASER SINTERING 3D PRINTING  This is a type of 3D printing technique. It involves powder bed being spread as thin layer laser radiations assessed to liquefy and fuse the powder layers. A lesser used method due to chemical degradation. The laser beam sinters the powder and binds it in layer by layer fashion.
  • 12. POWDER BASED 3D PRINTING  Powder based 3D printing uses powder jetting or powder bed to spread thin layers of powder and simultaneously apply liquid binder drops with the help of inkjet printers.  The ink (binders and APIs or Binder solutions) is sprinkled over a powder bed in two dimensional fashion to make the final product in a layer by layer fashion(12).
  • 13. CHALLENGES FACED DURING 3D PRINTING There are some challenges which are faced during 3D printing technique  Raw Material Selection: Printability, physiochemical characteristics, thermal conductivity are important factors. Print fluid characterization and viscoelastic property has to be carefully analysed with safety of raw material for human use.  Nozzle Selection: Nozzle mechanism is used for the dosage form during 3D printing. Some problems faced during this level are dogging of nozzles in printer head, scraping, migration of binder, bleeding and improper powder feeding.  Surface Imperfection In finished Product: Arrangement of plastic beads or large sized powder on top of each other requires drying time for the dosage form with powder based techniques and hence there is more possibility of surface imperfection
  • 15. APPLICATION OF 3DP TECHNOLOGY TO PHARMACEUTICAL DOSAGE FORMS 3DP technologies such as IJ(inkjet printing), FDM(fusion deposition modelling), and SLS(selective laser sintering) are currently available for manufacturing adequate pharmaceutical dosage forms  Tablets Tablets and capsules are examples of solid oral dosage forms. Tablets have been extensively examined for the feasibility of 3DP technologies in pharmaceutical manufacturing. Tablets produced by 3DP methods can be categorized into two groups: Single API tablets and Multiple API tablets.  Single API tablets 3DP technology was applied to fabricate simple immediate release (IR) tablets comprising a single. For example, a thermoplastic polyurethane-based dosage form loaded with 60% drug was successfully developed via the FDM(fusion deposition modeling)
  • 16. APPLICATION OF 3DP TECHNOLOGY TO PHARMACEUTICAL DOSAGE FORMS  Cellulose (EC/HPC/HPMC)/Eudragit L100, Ethylene vinyl acetate, hydroxypropyl cellulose, ethyl cellulose.  Multiple API tablets To combine complex medication regimes into one, multiple APIs can be loaded in a single tablet, called a poly pill The tablet is composed of three components, such as a surface-eroding polymer with the drug, surface-eroding polymer without the drug, and an impermeable polymer that forms a protective coating Figure 2- Polypills containing multiple active ingredients (APIs). a Polypill with three APIs, b polypill with five APIs
  • 17. APPLICATION OF 3DP TECHNOLOGY TO PHARMACEUTICAL DOSAGE FORMS  Microneedles:  Microneedles are a class of transdermal drug delivery systems, which has arrays of micron-sized needles on the surface of a matrix to enhance the skin penetration of biologically active molecules.  Microneedles may be more effective to deliver through the skin than traditional patches, due to its microstructure.  For eg: polymeric microneedles of complex geometries, by coupling 3DP with hydrogels casting/shrinking techniques
  • 18. NEED OF 3D PRINTING IN PHARMACEUTICALS 3D printing is used for personalized medicine and improvements in clinical trials, benefitting patients and manufacturers in pharmaceutical industry  Controlled Release: In controlled release systems, 3D Printing is used because of their tendency to change shape during digestion or operate for extended times, is growing as patients’ desire for convenience expands. Paediatric care is a key application area for extended-release pharmaceuticals. Extended release is an example of controlled release systems  Enhanced productivity: 3D printing technology is much faster than traditional method of drug manufacturing their tendency to change shape during digestion or operate for extended times
  • 19. NEED OF 3D PRINTING IN PHARMACEUTICALS  Short-Run Medicines: The short-run medicines which are used for 3D manufacturing themselves to patient-specific drugs 3D printing cans also use for clinical trial process through speed and flexibility and its ability to produce small batches of drugs with different compositions. With 3D printing, companies can create multiple versions of a drug for variant populations and produce them in short-run batches.
  • 20. CONCLUSION  3D printing technology is used for pharmaceutical manufacturing style and formulation techniques.  It is an important tool for pharmaceutical sector and health care sector. It is used as a personalized medicine which focused on the patients.It has high potential in individual dosage form.  3D printing is a possible platform for personalized medicine. Such techniques are also involved in 3D printing in pharmaceuticals for e.g. inkjet printing, powder based technology, etc.  Some need for 3D printing in pharmaceuticals. It can increase the cost. It is also used for enhancing productivity.  It is used for controlled release of drug, for enhancing productivity, and also for short run medicines
  • 21. REFERENCE  Norman J, Madurawe R, Moore C, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Advanced Drug Delivery Reviews.2017; 108:39-50.  Dingo JH. 3D Printing of Pharmaceutical Drug Delivery Systems. Archives of Organic and Inorganic Chemical Sciences.2018; 1(2).AOICS.MS.ID.000109.  Food and Drug Administration, 2017. Guidance for Industry: Technical Considerations for Additive Manufactured Medical Devices. Center for Devices and Radiological Health Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services.  https://www.fda.gov/http://cbm.msoe.edu/markMyweb/printResources/documen ts/historyOf3DPrinting.pdf 7. Wang, J, Goyanes A, Gaisford S, Basit AW. Stereolithographic (SLA)